Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study to Evaluate Next-Dose Transition From Zolpidem to Lemborexant (LEM) for the Treatment of Insomnia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04009577
Recruitment Status : Completed
First Posted : July 5, 2019
Last Update Posted : November 19, 2020
Sponsor:
Information provided by (Responsible Party):
Eisai Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : March 17, 2020
Actual Study Completion Date : June 26, 2020